The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Early detection of lung cancer with an incidental lung nodule program
Javier Zulueta, MD, Mount Sinai Morningside Hospital, New York, NY, discusses the implementation of an incidental lung nodule (ILN) program to improve follow-up rates and early detection of lung cancer. Using natural language processing to identify nodules in radiological reports, the program tracked patients with and without established follow-up pathways. Program engagement significantly improved follow-up compliance, leading to increased early-stage lung cancer diagnoses. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
